Save time and get answers to complex questions with AI chat
When oxcarbazepine patent expired?Complera manufacturer?Somatuline depot patent expiry date?Quartette side effects?Dabrafenib mesylate when the patent is expiring in india?
See the DrugPatentWatch profile for Auvelity
Auvelity is a prescription antidepressant approved for adults with major depressive disorder. - Pharmacologic class: Fixed-dose combination of dextromethorphan (NMDA receptor antagonist with sigma-1 receptor activity) and quinidine (a potent CYP2D6 inhibitor used to boost dextromethorphan levels). - Therapeutic classification: Antidepressant (glutamatergic-acting); often described as a rapid-acting oral antidepressant relative to traditional monoamine-based agents. - Mechanism (at a glance): Dextromethorphan blocks NMDA receptors and modulates glutamatergic signaling (plus sigma-1 activity); quinidine boosts exposure by inhibiting metabolism via CYP2D6. If you want, I can add details on indications, dosing, or safety.
Other Questions About Auvelity :